arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Strata Critical Medical, Inc.

SRTA

$5.80 ▲ +0.21 (+3.76%) at close

7 Visible periods

31 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Weak

Bullish

auto_awesome

Analytical Summary

Strata Critical Medical, Inc. shows strong fundamentals with top-quartile Return on Common Equity (%) and Profit Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $476.1M

Dividend Yield —

Revenue Growth -20.7% ↘

Op. Margin -11.3% ↗

ROIC -8.0% ↗

FCF / Share $-0.71 ↘

Trailing P/E 11.6x

Price / Book 1.7x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

7-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$197.14M

↓ -20.7% —

Net Income Profit after all expenses

$41.35M

↑ +251.4% —

Operating Margin Operating profit as % of sales

-11.3%

↑ +16.9% 14th

FCF / Share Free cash flow per share

$-0.71

↓ -65.4% —

trending_up

Bullish Indicators

Profit Margin (%)Profit Margin (%) is in the top quartile
Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns

Cash Quality

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Sep 30, 2020 10-K ↗	FY 2020 Sep 30, 2019 10-K ↗	FY 2019 Sep 30, 2018 10-K ↗
Revenue Growth YoY (%)	-20.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-359%)	10.4% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+31%)	345.7% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+4221%)	115.6% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1345%)	-24.9% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-411%)	—	—
EPS Growth YoY (%)	N/M	53.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	18.3% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	-132.5% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	7.0% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	—	—
Net Income Growth YoY (%)	N/M	51.3% Excellent ↑ Excellent Improving Year-over-year change in net income	-40.0% Weak ↑ Weak Improving Year-over-year change in net income	-294.2% Weak Weak Year-over-year change in net income	6.3% Fair Fair Year-over-year change in net income	—	—
FCF Growth YoY (%)	-65.4% Weak ↓ Weak Declining Year-over-year change in free cash flow	8.1% Fair ↑ Fair Improving Year-over-year change in free cash flow	-26.3% Weak ↓ Weak Declining Year-over-year change in free cash flow	16.4% Good Good Year-over-year change in free cash flow	-2.3% Weak Weak Year-over-year change in free cash flow	—	—
Revenue CAGR 3Y (%)	57.4% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	119.8% Excellent Excellent Compound annual revenue growth over 3 years	93.3% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	44.6% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Sep 30, 2020 10-K ↗	FY 2020 Sep 30, 2019 10-K ↗	FY 2019 Sep 30, 2018 10-K ↗
Operating Margin (%) (%)	-11.3% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-176%)	-13.6% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-191%)	-30.3% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-302%)	-47.7% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-418%)	-44.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-395%)	-37.0% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-347%)	—
Effective Tax Rate (%) (%)	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.9% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	2.5% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	8.3% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	21.0% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+75%)	-11.0% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-192%)	-24.9% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-308%)	-79.3% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-761%)	-43.4% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-461%)	-34.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-390%)	—
FCF Margin (%) (%)	-29.7% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-13.4% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-15.3% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-31.5% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-47.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-35.0% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	-1.42x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.22x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.61x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.40x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.10x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	1.01x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Sep 30, 2020 10-K ↗	FY 2020 Sep 30, 2019 10-K ↗	FY 2019 Sep 30, 2018 10-K ↗
Return on Invested Capital (%)	-8.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-15.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-28.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-7.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-93.5% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-55.7% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-6.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-13.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-23.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-7.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	-58.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	14.8% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: At sector avg	-12.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-182%)	-23.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-260%)	-13.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-192%)	-91.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-711%)	-52.3% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-448%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Sep 30, 2020 10-K ↗	FY 2020 Sep 30, 2019 10-K ↗	FY 2019 Sep 30, 2018 10-K ↗
Debt to Equity (x)	—	—	—	0.00x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	—	—	—
Interest Coverage (x)	—	—	—	-2007.75x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—
Net Debt (USD)	$-30.97M	$-18.38M	$-27.87M	$-6.95M	$-12.16M	$-22.18M	—
Debt / EBITDA (x)	—	—	—	0.00x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Sep 30, 2020 10-K ↗	FY 2020 Sep 30, 2019 10-K ↗	FY 2019 Sep 30, 2018 10-K ↗
Revenue per Share (USD)	$2.40	$3.21	$3.06	$1.18	$0.93	$1.24	—
Basic EPS, GAAP (USD)	$0.50	$-0.35	$-0.76	$-0.93	$-0.40	$-0.43	—
Free Cash Flow per Share (USD)	$-0.71	$-0.43	$-0.47	$-0.37	$-0.44	$-0.43	—
Book Value per Share (USD)	$3.40	$2.86	$3.19	$6.79	$0.44	$0.82	—
Tangible Book Value per Share (USD)	$1.75	$2.16	$2.36	$5.91	$0.42	$0.82	—
Basic Weighted Avg Shares (shares)	82.09M	77.50M	73.52M	42.88M	25.21M	25.14M	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Sep 30, 2020 10-K ↗	FY 2020 Sep 30, 2019 10-K ↗	FY 2019 Sep 30, 2018 10-K ↗
Working Capital (USD)	$106.40M	$138.02M	$170.77M	$282.16M	$8.04M	—	—
LT Debt (USD)	—	—	—	$0.00	—	—	—
Total Equity (USD)	$279.07M	$221.94M	$234.30M	$291.23M	$11.08M	$20.73M	$31.14M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Sep 30, 2020 10-K ↗	FY 2020 Sep 30, 2019 10-K ↗	FY 2019 Sep 30, 2018 10-K ↗
Sales/Revenue/Turnover (USD)	$197.14M	$248.69M	$225.18M	$50.53M	$23.43M	$31.20M	—
Depreciation Expense (USD)	$8.19M	$5.96M	$7.11M	$596.00K	$526.00K	$472.00K	—
Net Income, GAAP (USD)	$41.35M	$-27.31M	$-56.08M	$-40.05M	$-10.16M	$-10.84M	—
Operating Cash Flow (USD)	$-48.91M	$-2.52M	$-32.35M	$-15.62M	$-10.82M	$-10.30M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 26 quarters

Strata Critical Medical, Inc.

Analytical Summary

7-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare SRTA with peers